Cargando…

Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

Detalles Bibliográficos
Autores principales:	Birkisdóttir, María B., van Galen, Ivar, Brandt, Renata M. C., Barnhoorn, Sander, van Vliet, Nicole, van Dijk, Claire, Nagarajah, Bhawani, Imholz, Sandra, van Oostrom, Conny T., Reiling, Erwin, Gyenis, Ákos, Mastroberardino, Pier G., Jaarsma, Dick, van Steeg, Harry, Hoeijmakers, Jan H. J., Dollé, Martijn E. T., Vermeij, Wilbert P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727279/ https://www.ncbi.nlm.nih.gov/pubmed/36506463 http://dx.doi.org/10.3389/fragi.2022.1086552

Ejemplares similares

The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside
por: Birkisdóttir, María B., et al.
Publicado: (2022)

Unlike dietary restriction, rapamycin fails to extend lifespan and reduce transcription stress in progeroid DNA repair‐deficient mice
por: Birkisdóttir, María B., et al.
Publicado: (2021)

The Progeroid Phenotype of Ku80 Deficiency Is Dominant over DNA-PK(CS) Deficiency
por: Reiling, Erwin, et al.
Publicado: (2014)

Compromised DNA Repair Promotes the Accumulation of Regulatory T Cells With an Aging-Related Phenotype and Responsiveness
por: Pieren, Daan K. J., et al.
Publicado: (2021)

Gene expression changes in cerebellum induced by dietary restriction
por: van’t Sant, Lisanne J., et al.
Publicado: (2023)

Purkinje-cell-specific DNA repair-deficient mice reveal that dietary restriction protects neurons by cell-intrinsic preservation of genomic health
por: Birkisdóttir, María Björk, et al.
Publicado: (2023)

Diet restriction delays accelerated aging and genomic stress in DNA repair deficient mice
por: Vermeij, W.P., et al.
Publicado: (2016)

Cell-Autonomous Progeroid Changes in Conditional Mouse Models for Repair Endonuclease XPG Deficiency
por: Barnhoorn, Sander, et al.
Publicado: (2014)

Analysis of osteoarthritis in a mouse model of the progeroid human DNA repair syndrome trichothiodystrophy
por: Botter, Sander M., et al.
Publicado: (2010)

Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling
por: Alyodawi, Khalid, et al.
Publicado: (2019)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017)

Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease
por: Gaare, Johannes J., et al.
Publicado: (2023)

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022)

Broad segmental progeroid changes in short-lived Ercc1(−/Δ7) mice
por: Dollé, Martijn E.T., et al.
Publicado: (2011)

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
por: Veenhuis, Stefanie J.G., et al.
Publicado: (2021)

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
por: Delabie, Willem, et al.
Publicado: (2019)

Dihydronicotinamide riboside: synthesis from nicotinamide riboside chloride, purification and stability studies
por: Zarei, Amin, et al.
Publicado: (2021)

The Clinical Effects of Nicotinamide Riboside on Inflammatory Parameters
por: Kwon, Jun, et al.
Publicado: (2022)

Emerging Role of Nicotinamide Riboside in Health and Diseases
por: Sharma, Chiranjeev, et al.
Publicado: (2022)

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Ratajczak, Joanna, et al.
Publicado: (2016)

Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells
por: Kropotov, Andrey, et al.
Publicado: (2021)

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
por: Trammell, Samuel A. J., et al.
Publicado: (2016)

The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018)

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
por: Mehmel, Mario, et al.
Publicado: (2020)

The effects of in ovo nicotinamide riboside dose on broiler myogenesis
por: Xu, Xiaoxing, et al.
Publicado: (2020)

New Crystalline Salts of Nicotinamide Riboside as Food Additives
por: Schabert, Günter, et al.
Publicado: (2021)

Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
por: Zarei, Amin, et al.
Publicado: (2021)

Nicotinamide Riboside Supports Brain Health: Assessing the Evidence
por: Nkrumah-Elie, Yasmeen, et al.
Publicado: (2022)

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast
por: Orlandi, Ivan, et al.
Publicado: (2020)

In vivo 5-ethynyluridine (EU) labelling detects reduced transcription in Purkinje cell degeneration mouse mutants, but can itself induce neurodegeneration
por: van’t Sant, Lisanne J., et al.
Publicado: (2021)

In Vivo Renin Activity Imaging in the Kidney of Progeroid Ercc1 Mutant Mice
por: van Thiel, Bibi S., et al.
Publicado: (2021)

Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD(+)
por: Tempel, Wolfram, et al.
Publicado: (2007)

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
por: Trammell, Samuel A.J., et al.
Publicado: (2016)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects
por: Podyacheva, Ekaterina, et al.
Publicado: (2021)

Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022)

NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
por: Berven, Haakon, et al.
Publicado: (2023)

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

Going Back and Forth: Episomal Vector Reprogramming of Peripheral Blood Mononuclear Cells to Induced Pluripotent Stem Cells and Subsequent Differentiation into Cardiomyocytes and Neuron-Astrocyte Co-cultures
por: de Leeuw, Victoria C., et al.
Publicado: (2020)

Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease
por: Ahmadi, Armin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ddlsal9t5huvd1osq8fb5av8fb